Epigenetic mechanisms in coronary artery disease: The current state and prospects

Trends Cardiovasc Med. 2018 Jul;28(5):311-319. doi: 10.1016/j.tcm.2017.12.012. Epub 2017 Dec 30.

Abstract

Coronary artery disease (CAD) is the leading cause of morbidity and mortality. CAD has both genetic and environmental causes. In the past two decades, the understanding of epigenetics has advanced swiftly and vigorously. It has been demonstrated that epigenetic modifications are associated with the onset and progression of CAD. This review aims to improve the understanding of the epigenetic mechanisms closely related to CAD and to provide a novel perspective on the onset and development of CAD. Epigenetic changes include DNA methylation, histone modification, microRNA and lncRNA, which are interrelated with critical genes and influence the expression of those genes. In addition, miRNA plays a diverse role in the pathological process of CAD. Numerous studies have found that some cardiac-specific miRNAs have potential as certain diagnostic biomarkers and treatment targets for CAD. In this review, the aberrant epigenetic mechanisms that contribute to CAD will be discussed. We will also provide novel insight into the epigenetic mechanisms that target CAD.

Keywords: CAD; DNA methylation; Epigenetics; Histone modification; miRNA.

Publication types

  • Review

MeSH terms

  • Acetylation
  • Animals
  • Coronary Artery Disease / genetics*
  • Coronary Artery Disease / metabolism
  • Coronary Artery Disease / therapy
  • DNA Methylation
  • Epigenesis, Genetic*
  • Genetic Predisposition to Disease
  • Histones / metabolism
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Phenotype
  • Protein Processing, Post-Translational
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism
  • Risk Factors

Substances

  • Histones
  • MicroRNAs
  • RNA, Long Noncoding